1. Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection;Bassin;Virology,1982
2. CBER Note, 1993. Points to consider in the characterization of cell lines used to produce biologics. Center for Biologics Evaluation and Research.
3. CPMP Note for Guidance, 1995. The design, contribution and interpretation of studies validating the inactivation and removal of viruses. CPMP/BWP/268.
4. Process validation for virus removal;Darling;BioPharmacology,1996
5. FDA, 1998. Guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. Fed. Reg. 63 (185) 51074-51084.